Bal Pharma Limited (NSE: BALPHARMA)
India
· Delayed Price · Currency is INR 121.00
-1.95 (-1.59%)
Dec 26, 2024, 3:14 PM IST
Bal Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 76.63 | 73.92 | 25.72 | 56.12 | 47.42 | -122.18 | Upgrade
|
| Depreciation & Amortization | 81.34 | 77.74 | 72.11 | 78.52 | 83.33 | 63.44 | Upgrade
|
| Other Amortization | 22.97 | 22.97 | 19.18 | 11.88 | 11.88 | 13.34 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.08 | -0.83 | -0.3 | -12.34 | -0.21 | -0.53 | Upgrade
|
| Loss (Gain) From Sale of Investments | -11.8 | -11.8 | - | -0.06 | - | 0.15 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.93 | 1.93 | 1.82 | 1.59 | 2.12 | 2.24 | Upgrade
|
| Other Operating Activities | 121.35 | 104.54 | 141.36 | 115.64 | 106.8 | 96.61 | Upgrade
|
| Change in Accounts Receivable | 147.73 | -149.54 | -318.93 | -96.68 | -185 | 134.68 | Upgrade
|
| Change in Inventory | 56.02 | 101.94 | -236.09 | -140.1 | 73.26 | 20.4 | Upgrade
|
| Change in Accounts Payable | -10.99 | -5.95 | 271.73 | 205.94 | 89.81 | -87.52 | Upgrade
|
| Change in Other Net Operating Assets | -181.2 | 13.13 | 8.04 | 47.46 | -6.06 | 111.82 | Upgrade
|
| Operating Cash Flow | 303.91 | 228.06 | -15.37 | 267.96 | 223.35 | 232.43 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 19.97% | -3.91% | 199.62% | Upgrade
|
| Capital Expenditures | -171.19 | -109.8 | -146.45 | -84.69 | -33.64 | -50.63 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.56 | 0.12 | - | - | - | 0.18 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -9.79 | - | Upgrade
|
| Investment in Securities | -149.9 | -86.11 | -8.1 | -11.94 | -14.65 | - | Upgrade
|
| Other Investing Activities | 48.65 | 6.89 | -67.27 | 1.79 | 2.74 | 3.4 | Upgrade
|
| Investing Cash Flow | -271.89 | -188.91 | -221.82 | -94.85 | -55.35 | -47.05 | Upgrade
|
| Short-Term Debt Issued | - | 103.61 | 237.15 | - | - | 25.48 | Upgrade
|
| Long-Term Debt Issued | - | 58.26 | 117.02 | 30.81 | - | - | Upgrade
|
| Total Debt Issued | 142.56 | 161.88 | 354.17 | 30.81 | - | 25.48 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -93.3 | -92.59 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -36.64 | -87.97 | Upgrade
|
| Total Debt Repaid | 24.23 | - | - | -93.3 | -129.23 | -87.97 | Upgrade
|
| Net Debt Issued (Repaid) | 166.8 | 161.88 | 354.17 | -62.49 | -129.23 | -62.49 | Upgrade
|
| Issuance of Common Stock | 13.45 | 12.28 | 43.75 | - | 32.5 | - | Upgrade
|
| Common Dividends Paid | -19.11 | -15.69 | -15.57 | -14.82 | - | -14.17 | Upgrade
|
| Other Financing Activities | -174.73 | -170.53 | -141.41 | -94.91 | -69.6 | -123.07 | Upgrade
|
| Financing Cash Flow | -13.59 | -12.06 | 240.94 | -172.22 | -166.32 | -199.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0.04 | -1.42 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -12.18 | - | - | - | - | - | Upgrade
|
| Net Cash Flow | 6.25 | 27.09 | 3.74 | 0.89 | 1.65 | -15.77 | Upgrade
|
| Free Cash Flow | 132.72 | 118.26 | -161.83 | 183.26 | 189.71 | 181.8 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -3.40% | 4.35% | - | Upgrade
|
| Free Cash Flow Margin | 4.09% | 3.49% | -5.32% | 6.52% | 7.57% | 10.63% | Upgrade
|
| Free Cash Flow Per Share | 8.21 | 7.48 | -10.31 | 12.36 | 13.36 | 12.83 | Upgrade
|
| Cash Interest Paid | 167.4 | 163.26 | 136.83 | 104.04 | 116.06 | 123.07 | Upgrade
|
| Cash Income Tax Paid | 26.19 | 45.43 | 5.04 | 12.02 | 4.03 | 1.72 | Upgrade
|
| Levered Free Cash Flow | 5.43 | 20.21 | -234.05 | 92.28 | 64.91 | 168.29 | Upgrade
|
| Unlevered Free Cash Flow | 88.8 | 100.86 | -168.45 | 147.75 | 130.78 | 235.63 | Upgrade
|
| Change in Net Working Capital | -15.19 | 30.12 | 222.18 | -48.72 | 36.56 | -226.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.